Isturisa

Active Ingredient(s): Osilodrostat Phosphate
FDA Approved: * March 6, 2020
Pharm Company: * RECORDATI RARE
Category: Genetic Disorders

Osilodrostat, sold under the brand name Isturisa, is a medication for the treatment of adults with Cushing's disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the disease.[1] It is taken by mouth.[1] The most common side effects are adrenal insufficiency, headache, vomiting, nausea, fatigue, and edema (swelling caused by fluid retention).[1][2] Hypocortisolism (low cortisol lev... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Isturisa 1 mg Oral Tablet, Coated

NDC: 55292-320

Labeler:

Recordati Rare Diseases, Inc.

Isturisa 5 mg Oral Tablet, Coated

NDC: 55292-321

Labeler:

Recordati Rare Diseases, Inc.

Isturisa 10 mg Oral Tablet, Coated

NDC: 55292-322

Labeler:

Recordati Rare Diseases, Inc.